-
The pressure to publish pushes down quality
May 11, 2016, 10:09 AM by Michael CroftNature News & Comment | Scientists must publish less, says Daniel Sarewitz, or good research will be swamped by the ever-increasing volume of poor work.Full story -
10X, BioNano Publishes De Novo Assembly
May 10, 2016, 16:50 PM by Michael CroftBio-IT World News Brief Yesterday, 10x Genomics announced the publication of a study in Nature Methods highlighting the benefits of their GemCode Technology to generate high-quality assemblies of complex genomes with their proprietary Linked-Read approach. The article demonstrates a new strategy for performing rapid, accurate and cost-effective de novo genome assembly using 10x Genomics’ Linked-Reads in combination with technologies from BioNano.Full story -
Across The Board Ideas To Narrow Biotechs Gender Gap
May 10, 2016, 15:44 PM by Michael CroftXconomy | The evidence is piling up. Companies with more women in charge are better businesses. So why are so many biotechs still led mainly by men?Full story -
Definiens’ Symposium Finds Tissue Context of Tumor is Key to Cancer Immunotherapy Success
May 10, 2016, 15:30 PM by Michael CroftMUNICH, GERMANY - May 10, 2016 - Definiens, the pioneer in Tissue Phenomics® solutions for diagnostics development, has announced findings from the International Symposium, a sold-out gathering of international researchers and clinicians on April 27-28 in Boston, Massachusetts to discuss advancements in oncology and the application of Tissue PhenomicsFull story -
IOMICS Announces Innovative Data Analytics Platform for Chemical Engineering, Medical Research, and Clinical Care.
May 10, 2016, 14:49 PM by Michael CroftBOSTON, MA - May 10, 2016 - IOMICS Announces Innovative Data Analytics Platform for Chemical Engineering, Medical Research, and Clinical CarexFull story -
Rho to Discuss Clinical Trial Experience at American Pain Society 35th Annual Scientific Meeting 2016
May 10, 2016, 13:06 PM by Michael CroftCHAPEL HILL, NC, UNITED STATES - May 10, 2016 - WHAT: Rho, a full-service contract research organization (CRO), will highlight its clinical trial expertise during the American Pain Society's (APS) 35th Annual Scientific Meeting, being held May 11-14 in Austin, TexasFull story -
IBMs Watson is going to cybersecurity school
May 10, 2016, 11:21 AM by Michael CroftComputerworld | The result will be a cloud service called Watson for Cyber Security that's designed to provide insights into emerging threats as well as recommendations on how to stop them.Full story -
CRISPR Drug Maker Intellia Therapeutics Sells $108M In IPO Shares
May 6, 2016, 10:06 AM by Michael CroftXconomy | The latest biopharmaceutical company testing Wall Street's belief in the promise of gene modification has gone public. Intellia Therapeutics sold 6 million shares at $18 each to raise $108 million.Full story -
Gene Therapy’s First Out-and-Out Cure Is Here
May 6, 2016, 10:05 AM by Michael CroftMIT Technology Review | A genetic therapy for "bubble boy" disease completes a 27-year journey.Full story -
The New Parasite Award Recognizes Secondary Analysis of Data
May 5, 2016, 13:06 PM by Michael CroftSTAT | The current incentives structure - mostly based on publishing in prestigious journals - discourages sharing, replication, and, some argue, careful science.Full story -
Tech groups call on presidential candidates to support encryption embrace other IT issues
May 5, 2016, 12:42 PM by Michael CroftComputerworld | U.S. presidential candidates should embrace encryption and narrow government access to Internet users' data as part of a comprehensive technology agenda, 13 IT trade groups recommended.Full story -
How Blockchain Is Helping Genomics Research
May 4, 2016, 10:50 AM by Michael CroftBio-IT World | John Mattison predicts that blockchain, "is going to be the most disruptive technology in this space other than big-data analytics."Full story -
The World’s Most Expensive Medicine Is a Bust
May 4, 2016, 10:22 AM by Michael CroftMIT Technology Review | The first gene therapy approved in the Western world costs $1 million and has been used just once. The doctor who tried it says the price is "absolutely too high."Full story -
IBM launches quantum computing for the rest of us
May 4, 2016, 10:20 AM by Michael CroftMashable | IBM unveiled the world's first cloud-based quantum computing experience. Starting today, anyone can access the quantum computing hardware based at IBM's T.J. Watson Research Center in Yorktown Heights, New York.Full story -
Sinequa Ushers in The Era of Cognitive Computing with New Version of Its Cognitive Insight Platform
May 3, 2016, 16:44 PM by Michael CroftNEW YORK, NY - May 3, 2016 - Sinequa today announced the general availability of Sinequa ES Version 10. Powered by Machine Learning capabilities at its core, this ground breaking version helps deliver deep analytics of contents and user behavior, offering information with continually improving relevance to users in their work environmentsFull story -
This MIT employee redefined how universities launch startups
May 3, 2016, 08:16 AM by Michael CroftSTAT | Lita Nelsen of the Technology Licensing Office at MIT became an evangelist for tech transfer and a mentor to her counterparts around the world.Full story -
Genomic Data and Drug Development EMA Offers New Draft Guidance
May 2, 2016, 14:52 PM by Michael CroftRAPS | The European Medicines Agency has released a new draft guidance to provide industry with more insight on how to identify and understand genomic factors that influence drug responses.Full story -
The Struggle With Image Glut
May 2, 2016, 12:40 PM by Michael CroftNature News & Comment | Experiments that generate millions of images have forced scientists to find new ways to store and share terabytes of experimental data.Full story -
Three Pharma Data Challenges and How to Overcome Them
Apr 29, 2016, 10:35 AM by Michael CroftFull storyBio-IT World | Contributed Commentary | There’s no lack of ideas about what is needed to make advancements in life sciences research and improving patient care: real-time research, humanizing big data, enhancing customer values and motivation, and that’s just for starters. It was evident that these data struggles were on the minds of attendees at the recent Bio-IT World 2016 Conference in Boston.
-
twoXAR Joins Stanford University in Hunt for Medicines Targeting Rare Diseases
Apr 28, 2016, 10:53 AM by Michael CroftPALO ALTO, CA - Apr 28, 2016 - twoXAR, Inc., a company dedicated to improving health through computation, today announced a collaboration with Joyce Teng, MD, PhD, of the Department of Dermatology at Stanford University to support research focused on the identification of drug candidates targeting rare disorders such as lymphatic malformation and epidermolysis bullosa simplex (EBS)Full story